New Momentum in the Pharmaceutical Sector in Morocco: SPE Capital and Proparco sell Amanys Pharma to Laprophan

November 11, 2023 – SPE Capital, an independent private equity firm, announces the sale of Amanys Pharma to Laprophan, a pioneering pharmaceutical company in Morocco, subject to obtaining the required regulatory approvals. This transaction constitutes the second exit for SPE AIF, the USD 260m African-focused fund managed by SPE Capital and which reached final close December 2020.

Oury Medical, a portfolio company of SPE France, announces the acquisition of MGC and Imprint Medical in order to strengthen its position as one-stop-shop for surgical instrumentation

Nogent, Wednesday, November 8, 2023 In a strategic move designed to reinforce its status as a global partner in the supply of surgical instruments, Oury Medical is delighted to announce the acquisitions of Metal Global Concept (MGC) and of Imprint Medical. These acquisitions follow that of SMAO last December and reinforce the expansion strategy of the Oury Medical group orchestrated by SPE Capital since its investment in October 2022. Oury Medical's ambition is to support its orthopedic customers from the design stage right through to mass production, with tailored, innovative solutions for all surgical instrumentation needs.

Less than six months after SPE Capital investment, Oury-Guye et Fils (OURY-GUYE) has completed its first build-up with the acquisition of Société Marnaise d'Applications Orthopédiques (SMAO)

Nogent, January 10, 2023 With the support of SPE Capital, OURY-GUYE strengthens its position in the surgical instrumentation sector with the acquisition of SMAO, a company specializing in the production of cutting tools, drills and ancillary equipment. Based in Nogent in the Haute-Marne region, OURY-GUYE is a century-old medical device company, a member of the French Fab and a French Living Heritage Company (E.P.V.). With the investment of SPE Capital in September 2022, OURY-GUYE aims to position itself as a strategic partner in medical instrumentation in France and internationally.

SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia

January 4th, 2023- SPE Capital, an investment firm focused on Africa and the Middle East, announces the acquisition, by its private equity fund SPE AIF I, of a majority stake in Vital, the leading nutritional supplements producer in Tunisia. Vital constitutes the fund’s 9th investment and the 4th in 2022.

Basile Phelipeau

SPE Capital is pleased to announce that Basile Phelipeau has joined the firm as Associate Partner of the France small-cap initiative, to be based out of the Paris office. He will contribute to developing the business further and strengthening the firm’s activities in France and across Europe.

SPE Capital announces the election of Tarek Lababidi to Partner

SPE Capital is delighted to announce the election to Partner of Tarek Lababidi.

The Moroccan group OUTSOURCIA acquires Tunisia's leading contact center operator PHONEACT

SPE Capital, in partnership with Tioopo Capital, acquires a majority stake in Oury-Guye et Fils (OURY- GUYE), a leading French manufacturer of orthopedics and spine instruments.

OURY-GUYE is a century-old company that designs and manufactures high-precision orthopedics and spine surgical instruments.

SPE Capital agrees to sell a controlling stake in Sotipapier to Sango Capital

August 5 th , 2022- SPE Capital Partners is pleased to announce the signing of an agreement to sell a controlling stake in Sotipapier, the leading paper packaging manufacturer in Tunisia, to Sango Capital. In addition to acquiring a majority stake in Sotipapier, Sango Capital plans to proceed to a tender offer in accordance with regulations in force. This agreement remains subject to the obtention of the required authorizations from the competent authorities.

SPE Capital announces an agreement for the acquisition of a majority stake in Outsourcia group

SPE Capital announces an agreement for the acquisition of a majority stake in Outsourcia group

SPE Capital acquires GlobalCorp, a leading non-bank financial player in Egypt, alongside Amethis and EBRD

SPE Capital acquires GlobalCorp, a leading non-bank financial player in Egypt, alongside Amethis and EBRD

SPE Capital acquires strategic minority stake in Holged from TPG Growth and Satya Capital

SPE Capital acquires strategic minority stake in Holged from TPG Growth and Satya Capital

Ahmed El Oraby

SPE Capital announces the promotion of Ahmed El Oraby to Partner

Dislog Group

Dislog Group and SPE Capital Partners announce the exit of SPE AIF I from H&S Invest Holding

Ademat

SPE Capital acquires leading provider of power security solutions in Côte d’Ivoire

Final close of SPE AIF I

SPE Capital Holds Final Close of SPE AIF I

Stéphane Heuzé

SPE Capital grows leadership team with new Managing Partner

Saham Pharma

SPE AIF I and Proparco acquire Saham Pharma, a leading antibiotics manufacturer and major hospital provider in Morocco

Dislog Group

SPE AIF I invests in H&S Invest Holding Group, the leading fully integrated FMCG distributor in Morocco

Future Pharmaceutical Industries

SPE AIF I invests in Future Pharmaceutical Industries, a fast-growing Egyptian generic pharmaceuticals manufacturer

Sotipapier

SPE Capital successfully completes a dividend recapitalization, partial exit and capital increase in relation to its investment in Sotipapier

Orchidia Pharmaceutical Industries

SPE Capital successfully exits its investment in orchidia pharmaceutical industries

International School of Carthage

Meninx Holding and SPE Capital successfully acquired the International School of Carthage (ISC)